These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 11780466

  • 1. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
    Wang X, Sun B, Zhou F, Hu J, Yu X, Peng T.
    Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
    [Abstract] [Full Text] [Related]

  • 2. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.
    Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y.
    J Clin Invest; 1993 Sep; 92(3):1436-43. PubMed ID: 8397225
    [Abstract] [Full Text] [Related]

  • 3. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
    Mao J, Wang M, Ni L, Gong W, Jiang X, Zhang Q, Zhang M, Wen D, Chen J.
    Endocrinology; 2021 Jul 01; 162(7):. PubMed ID: 33912936
    [Abstract] [Full Text] [Related]

  • 4. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A, Canalejo R, Rodriguez ME, Martinez-Moreno JM, Felsenfeld AJ, Rodríguez M, Almaden Y.
    Nephrol Dial Transplant; 2010 Apr 01; 25(4):1087-97. PubMed ID: 19934096
    [Abstract] [Full Text] [Related]

  • 5. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.
    Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M.
    Ther Apher Dial; 2005 Aug 01; 9 Suppl 1():S27-34. PubMed ID: 16109139
    [Abstract] [Full Text] [Related]

  • 6. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H.
    Kidney Int; 2002 Oct 01; 62(4):1196-207. PubMed ID: 12234290
    [Abstract] [Full Text] [Related]

  • 7. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
    Latus J, Lehmann R, Roesel M, Fritz P, Braun N, Ulmer C, Steurer W, Biegger D, Ott G, Dippon J, Alscher MD, Kimmel M.
    Kidney Blood Press Res; 2013 Oct 01; 37(1):84-94. PubMed ID: 23552627
    [Abstract] [Full Text] [Related]

  • 8. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
    Yamaguchi S, Yachiku S, Morikawa M.
    J Clin Endocrinol Metab; 1997 Aug 01; 82(8):2681-8. PubMed ID: 9253354
    [Abstract] [Full Text] [Related]

  • 9. Parathyroid growth and suppression in renal failure.
    Lewin E, Huan J, Olgaard K.
    Semin Dial; 2006 Aug 01; 19(3):238-45. PubMed ID: 16689976
    [Abstract] [Full Text] [Related]

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 11. The calcium-sensing receptor and vitamin D receptor expression in tertiary hyperparathyroidism.
    Grzela T, Chudzinski W, Lasiecka Z, Niderla J, Wilczynski G, Gornicka B, Wasiutynski A, Durlik M, Boszczyk A, Brawura-Biskupski-Samaha R, Dziunycz P, Milewski L, Lazarczyk M, Lazarczyk M, Nawrot I.
    Int J Mol Med; 2006 May 01; 17(5):779-83. PubMed ID: 16596260
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
    Martin LN, Kayath MJ, Vieira JG, Nosé-Alberti V.
    Histopathology; 1998 Jul 01; 33(1):46-51. PubMed ID: 9726048
    [Abstract] [Full Text] [Related]

  • 13. Vitamin D-independent therapeutic effects of extracellular calcium in a mouse model of adult-onset secondary hyperparathyroidism.
    Weber K, Bergow C, Hirmer S, Schüler C, Erben RG.
    J Bone Miner Res; 2009 Jan 01; 24(1):22-32. PubMed ID: 18767932
    [Abstract] [Full Text] [Related]

  • 14. [The mechanisms of parathyroid hyperplasia and its regression].
    Tokumoto M, Taniguchi M.
    Clin Calcium; 2007 May 01; 17(5):665-76. PubMed ID: 17470994
    [Abstract] [Full Text] [Related]

  • 15. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T, Rastad J, Szabó E, Westin G, Akerström G.
    J Clin Endocrinol Metab; 2000 May 01; 85(5):2000-3. PubMed ID: 10843188
    [Abstract] [Full Text] [Related]

  • 16. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor and cyclin-dependent kinase inhibitors, p21 and p27.
    Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H, Iida M.
    Nephrol Dial Transplant; 2003 Jun 01; 18 Suppl 3():iii9-12. PubMed ID: 12771291
    [Abstract] [Full Text] [Related]

  • 17. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
    Lee HJ, Seo UH, Kim WY, Woo SU, Lee JB.
    J Int Med Res; 2013 Feb 01; 41(1):97-105. PubMed ID: 23569134
    [Abstract] [Full Text] [Related]

  • 18. NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.
    Kan S, Zhang W, Mao J, Wang M, Ni L, Zhang M, Zhang Q, Chen J.
    J Nephrol; 2018 Dec 01; 31(6):941-951. PubMed ID: 30171599
    [Abstract] [Full Text] [Related]

  • 19. Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.
    Kumata C, Mizobuchi M, Ogata H, Koiwa F, Nakazawa A, Kondo F, Kadokura Y, Kinugasa E, Akizawa T.
    Am J Nephrol; 2010 Dec 01; 31(3):230-8. PubMed ID: 20068287
    [Abstract] [Full Text] [Related]

  • 20. Proliferating potential and apoptosis in the development of secondary hyperparathyroidism: a study based on Ki-67 immunohistochemical staining and the terminal dUTP nick-end labeling assay.
    Wada Y, Kunimura T, Sato S, Hisayuki T, Sato M, Imataka H, Yamashita N, Akizawa T, Moroboshi T.
    Ther Apher Dial; 2008 Aug 01; 12(4):319-28. PubMed ID: 18789120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.